Stay updated with breaking news from Patrick Tippoo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Political leaders gathering at the UN's first high-level discussion on pandemic preparedness in New York will on Thursday have one more chance to put measures in place to prevent the catastrophes that played out during the Covid-19 pandemic being repeated.
A newly published report has highlighted the steps that need to be taken to close the significant gap between the current less than 1% of vaccine doses supplied to African countries that are African-manufactured, and the goal of reaching 60% by 2040, as envisioned by Partnerships for African Vaccine Manufacturing (PAVM). The report, titled “Scaling up African vaccine manufacturing capacity”, which was put together by UK charity foundation Wellcome, South African biopharmaceutical company Biovac and global management consulting firm Boston Consulting Group (BCG), noted several major...
Leaders on the continent have vowed that if there is another pandemic, they won’t be shut out of the vaccine market.
Europe has promised millions of euros to set up vaccine manufacturing in Africa, but cash alone won’t be enough.
The COVID-19 pandemic highlighted the urgent need to build capacity to develop and manufacture much-needed vaccines in Africa. Patrick Tippoo, Executive Director of the African Vaccine Manufacturing Initiative (AVMI), explains why vaccine independence for Africa is so important.